Literature DB >> 16049865

Potential clinical uses of neuroactive steroids.

C F Zorumski1, S Mennerick, K E Isenberg, D F Covey.   

Abstract

Neuroactive steroids rapidly modulate gamma-aminobutyric acid (GABA) and glutamate receptors. GABA-enhancing steroids have potential clinical utility as anesthetics, hypnotics, anticonvulsants and anxiolytics. Furthermore, GABAergic neurosteroids may participate in regulating mood and the effects of alcohol on the nervous system, suggesting a potential role in major psychiatric disorders. Neuroactive steroids that alter the function of glutamate receptors could be useful for treating neurodegenerative disorders, and as cognitive enhancers. Recent progress in developing water-soluble steroids and steroids with enhanced oral efficacy foster optimism that certain neuroactive steroids will be developed for clinical use.

Entities:  

Year:  2000        PMID: 16049865

Source DB:  PubMed          Journal:  IDrugs        ISSN: 1369-7056


  4 in total

1.  Neurosteroid analogues. 17. Inverted binding orientations of androsterone enantiomers at the steroid potentiation site on γ-aminobutyric acid type A receptors.

Authors:  Kathiresan Krishnan; Brad D Manion; Amanda Taylor; John Bracamontes; Joseph H Steinbach; David E Reichert; Alex S Evers; Charles F Zorumski; Steven Mennerick; Douglas F Covey
Journal:  J Med Chem       Date:  2012-01-18       Impact factor: 7.446

2.  Structurally diverse amphiphiles exhibit biphasic modulation of GABAA receptors: similarities and differences with neurosteroid actions.

Authors:  M Chisari; H-J Shu; A Taylor; J H Steinbach; C F Zorumski; Steven Mennerick
Journal:  Br J Pharmacol       Date:  2010-05       Impact factor: 8.739

Review 3.  Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications.

Authors:  HuaLin Cai; Ting Cao; Xiang Zhou; Jeffrey K Yao
Journal:  Front Psychiatry       Date:  2018-03-08       Impact factor: 4.157

4.  Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABAA receptor positive allosteric modulator.

Authors:  Alison L Althaus; Michael A Ackley; Gabriel M Belfort; Steven M Gee; Jing Dai; David P Nguyen; Tatiana M Kazdoba; Amit Modgil; Paul A Davies; Stephen J Moss; Francesco G Salituro; Ethan Hoffmann; Rebecca S Hammond; Albert J Robichaud; Michael C Quirk; James J Doherty
Journal:  Neuropharmacology       Date:  2020-09-22       Impact factor: 5.250

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.